Becton Dickinson EPS - Earnings per Share 2010-2024 | BDX

Becton Dickinson annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Becton Dickinson EPS for the quarter ending March 31, 2024 was $1.85, a 20.92% increase year-over-year.
  • Becton Dickinson EPS for the twelve months ending March 31, 2024 was $4.52, a 15.2% decline year-over-year.
  • Becton Dickinson 2023 annual EPS was $4.94, a 15.99% decline from 2022.
  • Becton Dickinson 2022 annual EPS was $5.88, a 14.16% decline from 2021.
  • Becton Dickinson 2021 annual EPS was $6.85, a 152.77% increase from 2020.
Becton Dickinson Annual EPS
2023 $4.94
2022 $5.88
2021 $6.85
2020 $2.71
2019 $3.94
2018 $0.60
2017 $4.60
2016 $4.49
2015 $3.35
2014 $5.99
2013 $6.49
2012 $5.59
2011 $5.62
2010 $5.49
2009 $4.99
Becton Dickinson Quarterly EPS
2024-03-31 $1.85
2023-12-31 $0.96
2023-09-30 $0.35
2023-06-30 $1.36
2023-03-31 $1.53
2022-12-31 $1.70
2022-09-30 $0.92
2022-06-30 $1.18
2022-03-31 $1.50
2021-12-31 $2.28
2021-09-30 $0.84
2021-06-30 $1.72
2021-03-31 $0.94
2020-12-31 $3.35
2020-09-30 $0.34
2020-06-30 $0.97
2020-03-31 $0.53
2019-12-31 $0.87
2019-09-30 $0.45
2019-06-30 $1.51
2019-03-31 $-0.07
2018-12-31 $2.05
2018-09-30 $-0.48
2018-06-30 $2.03
2018-03-31 $-0.19
2017-12-31 $-0.76
2017-09-30 $1.19
2017-06-30 $-0.75
2017-03-31 $1.58
2016-12-31 $2.58
2016-09-30 $0.07
2016-06-30 $1.80
2016-03-31 $1.56
2015-12-31 $1.06
2015-09-30 $0.78
2015-06-30 $0.29
2015-03-31 $1.08
2014-12-31 $1.20
2014-09-30 $1.52
2014-06-30 $1.65
2014-03-31 $1.45
2013-12-31 $1.37
2013-09-30 $0.45
2013-06-30 $1.52
2013-03-31 $1.39
2012-12-31 $3.13
2012-09-30 $1.40
2012-06-30 $1.59
2012-03-31 $1.39
2011-12-31 $1.21
2011-09-30 $1.35
2011-06-30 $1.53
2011-03-31 $1.38
2010-12-31 $1.36
2010-09-30 $1.66
2010-06-30 $1.29
2010-03-31 $1.24
2009-12-31 $1.30
2009-09-30 $1.28
2009-06-30 $1.39
2009-03-31 $1.06
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.549B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.372B 21.99
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00